Machine-Learning Models Could Help ID MASH Patients Considered Candidates for Resmetirom
New data suggest leveraging artificial intelligence, more specifically metabolomics-based machine learning models, could help revolutionize screening for identifying patients with metabolic dysfunction-associated steatohepatitis (MASH) who would be …